< Back to previous page
Researcher
Chia-Te Liao
- Disciplines:Health economy, Cardiology
Affiliations
- Hypertension and Cardiovascular Epidemiology (Division)
Member
From13 Apr 2022 → Today
Projects
1 - 1 of 1
- Analysis of the Effectiveness and Economic Viability of Different Cardiovascular Disease Treatment and Prevention Strategies in Various SubpopulationsFrom1 Mar 2022 → 27 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 13
- Taiwan renal data report system: Framework, function, and development(2023)
Authors: Chia-Te Liao
Pages: 581 - 587 - Iron deficiency in Taiwanese patients with heart failure and reduced ejection fraction(2023)
Authors: Chia-Te Liao
Pages: 725 - 731 - Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial-First progress report(2023)
Authors: Chia-Te Liao, Tim Nawrot, Kei Asayama, Jan A Staessen
Pages: 521 - 533 - The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials(2023)
Authors: Chia-Te Liao
- Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy(2023)
Authors: Chia-Te Liao
- Analysis of the Effectiveness and Economic Viability of Different Cardiovascular Disease Treatment and Prevention Strategies in Various Subpopulations(2023)
Authors: Chia-Te Liao, Zhenyu Zhang
- Real-World Experience of Angiotensin Receptor-Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease(2023)
Authors: Chia-Te Liao
Pages: 88 - 99 - Economic evaluation of new blood pressure target for hypertensive patients in Taiwan according to the 2022 hypertension clinical practice guidelines of the Taiwan society of cardiology: a simulation modeling study(2023)
Authors: Chia-Te Liao
Pages: 187 - 199 - Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials(2022)
Authors: Chia-Te Liao
- Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis(2022)
Authors: Dongmei Wei, Zhenyu Zhang, Chia-Te Liao